Virginia Senkomago1, Danielle M Backes2, Michael G Hudgens3, Charles Poole1, Kawango Agot4, Stephen Moses5, Peter J F Snijders6, Chris J L M Meijer6, Albertus T Hesselink6, Nicolas F Schlecht7, Robert C Bailey8, Jennifer S Smith9. 1. Department of Epidemiology. 2. Department of Epidemiology Department of Epidemiology, Brown Public Health, Brown University, Providence, Rhode Island. 3. Department of Biostatistics, Gillings School of Global Public Health. 4. Impact Research and Development Organization, Kisumu, Kenya. 5. Centre for Global Public Health, University of Manitoba, Winnipeg, Canada. 6. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. 7. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, New York. 8. Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois, Chicago. 9. Department of Epidemiology Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
Abstract
BACKGROUND: Circumcision and lower human papillomavirus (HPV) viral loads in men are possibly associated with a reduced risk of HPV transmission to women. However, the association between male circumcision and HPV viral load remains unclear. METHODS:Swab specimens from the glans and shaft of the penis were collected from men enrolled in a circumcision trial in Kisumu, Kenya. GP5+/6+ polymerase chain reaction (PCR) was used to identify HPV DNA types. HPV-16and HPV-18 loads were measured with a LightCycler real-time PCR and classified as high (>250 copies/scrape) or low (≤250 copies/scrape). RESULTS:A total of 1159 men were randomly assigned to undergo immediate circumcision, and 1140 men were randomly assigned to the control arm (these individuals were asked to remain uncircumcised until the study ended). The hazard of acquisition of high-viral load infections in the glans was lower in the circumcision arm, compared with the control arm, for HPV-16 (hazard ratio [HR], 0.32 [95% confidence interval {CI}, .20-.49]) and HPV-18 (HR, 0.34 [95% CI, .21-.54]). The 6-month risk of HPV persistence among men with high-viral load infections in the glans at baseline was lower in the circumcision arm, compared with the control arm, for HPV-16 (risk ratio [RR], 0.36 [95% CI, .18-.72]) and HPV-18 (RR 0.34 [95% CI, .13-.86]). Weaker and less precise results were obtained for shaft samples. CONCLUSIONS: Male circumcision could potentially reduce the risk of HPV transmission to women by reducing the hazard of acquisition, and the risk of persistence of high-HPV viral load infections in the glans in men.
RCT Entities:
BACKGROUND: Circumcision and lower human papillomavirus (HPV) viral loads in men are possibly associated with a reduced risk of HPV transmission to women. However, the association between male circumcision and HPV viral load remains unclear. METHODS: Swab specimens from the glans and shaft of the penis were collected from men enrolled in a circumcision trial in Kisumu, Kenya. GP5+/6+ polymerase chain reaction (PCR) was used to identify HPV DNA types. HPV-16 and HPV-18 loads were measured with a LightCycler real-time PCR and classified as high (>250 copies/scrape) or low (≤250 copies/scrape). RESULTS: A total of 1159 men were randomly assigned to undergo immediate circumcision, and 1140 men were randomly assigned to the control arm (these individuals were asked to remain uncircumcised until the study ended). The hazard of acquisition of high-viral load infections in the glans was lower in the circumcision arm, compared with the control arm, for HPV-16 (hazard ratio [HR], 0.32 [95% confidence interval {CI}, .20-.49]) and HPV-18 (HR, 0.34 [95% CI, .21-.54]). The 6-month risk of HPV persistence among men with high-viral load infections in the glans at baseline was lower in the circumcision arm, compared with the control arm, for HPV-16 (risk ratio [RR], 0.36 [95% CI, .18-.72]) and HPV-18 (RR 0.34 [95% CI, .13-.86]). Weaker and less precise results were obtained for shaft samples. CONCLUSIONS: Male circumcision could potentially reduce the risk of HPV transmission to women by reducing the hazard of acquisition, and the risk of persistence of high-HPV viral load infections in the glans in men.
Authors: Danielle M Backes; Maaike C G Bleeker; Chris J L M Meijer; Michael G Hudgens; Kawango Agot; Robert C Bailey; J O Ndinya-Achola; Juma Hayombe; Cornelis J A Hogewoning; Stephen Moses; Peter J F Snijders; Jennifer S Smith Journal: Int J Cancer Date: 2011-08-02 Impact factor: 7.396
Authors: Aaron A R Tobian; Xiangrong Kong; Maria J Wawer; Godfrey Kigozi; Patti E Gravitt; David Serwadda; Kevin P Eaton; Fred Nalugoda; Thomas C Quinn; Ronald H Gray Journal: Lancet Infect Dis Date: 2011-04-12 Impact factor: 25.071
Authors: A T Hesselink; A J C van den Brule; Z M A Groothuismink; M Molano; J Berkhof; C J L M Meijer; P J F Snijders Journal: J Clin Microbiol Date: 2005-09 Impact factor: 5.948
Authors: Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford Journal: Int J Cancer Date: 2007-08-01 Impact factor: 7.396
Authors: Philip E Castle; Mark Schiffman; David R Scott; Mark E Sherman; Andrew G Glass; Brenda B Rush; John E Schussler; Sholom Wacholder; Attila T Lorincz Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: Maaike C G Bleeker; Cornelis J A Hogewoning; Feja J Voorhorst; Adriaan J C van den Brule; Johannes Berkhof; Albertus T Hesselink; Marjolein Lettink; Theo M Starink; Tom J Stoof; Peter J F Snijders; Chris J L M Meijer Journal: Int J Cancer Date: 2005-01-01 Impact factor: 7.396
Authors: Mitzie-Ann Davis; Ronald H Gray; Mary K Grabowski; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Stephen Watya; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian Journal: Int J Cancer Date: 2013-03-07 Impact factor: 7.396
Authors: Lauren E Wilson; Patti Gravitt; Aaron A R Tobian; Godfrey Kigozi; David Serwadda; Fred Nalugoda; Stephen Watya; Maria J Wawer; Ronald H Gray Journal: Sex Transm Infect Date: 2012-10-30 Impact factor: 3.519
Authors: Mary K Grabowski; Patti E Gravitt; Ronald H Gray; David Serwadda; Andrew D Redd; Godfrey Kigozi; Xiangrong Kong; Fred Nalugoda; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian Journal: J Infect Dis Date: 2017-03-01 Impact factor: 5.226
Authors: Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Steven R Meshnick; Kawango Agot; Stephen Moses; Peter Jf Snijders; Chris Jlm Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith Journal: Sex Transm Dis Date: 2016-09 Impact factor: 2.830
Authors: Jennifer S Smith; Danielle M Backes; Michael G Hudgens; Wenwen Mei; Hrishikesh Chakraborty; Eliane Rohner; Stephen Moses; Kawango Agot; Chris J L M Meijer; Robert C Bailey Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-05-10 Impact factor: 4.254
Authors: Aaron A R Tobian; Godfrey Kigozi; Jordyn Manucci; Mary K Grabowski; David Serwadda; Richard Musoke; Andrew D Redd; Fred Nalugoda; Steven J Reynolds; Nehemiah Kighoma; Oliver Laeyendecker; Justin Lessler; Ronald H Gray; Thomas C Quinn; Maria J Wawer Journal: PLoS Med Date: 2015-04-28 Impact factor: 11.069